• Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate
  • Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate
  • Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate
  • Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate
  • Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate
  • Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate

Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate

Powder: Yes
Customized: Ready to Ship
Certification: GMP, USP, BP
Suitable for: Adult
State: Solid
Purity: >99%
Samples:
US$ 1/g 1 g(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory
  • Overview
  • Product Description
  • Our Advantages
Overview

Basic Info.

Model NO.
01-1
Other Name
(Arry-470)
Sample
Free
Application
for Antibacteria
Impurity
0.01%
Assay
99.5%
Residual Solvent
Ethanol
Annul Sales
2000kg
Heavy Metal
10ppm
Capacity
2500kg
Stock
2.00kg
Water
0.01%
Market
India
Ever Exported?
Yes
Volume
200kg
Experience
10years
Transport Package
Air
Specification
JP
Trademark
jianfeng
Origin
Shandong
HS Code
2934999988
Production Capacity
400kg

Product Description

Product Description

Lapatinib ditosylate powder cas 388082-77-7 

Breast cancer remains a leading cause of disease and death among women throughout the world. Despite advances in drug therapy, development of novel and improved drugs for breast cancer continues to be of great interest. Lapatinib is a novel dual receptor tyrosine kinase inhibitor that is a selective and potent inhibitor of ErbB-1 and ErbB-2 tyrosine kinases, both of which are growth promoting factors overexpressed in some breast cancers.
Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate salt (trade name TYKERB). Lapatinib is dual inhibitor of the EGFR (epidermal receptor; also called HER1 or ErbB1) and HER2 receptor tyrosine kinases. Lapatinib was developed by GlaxoSmithKline, however, Novartis subsequently acquired all the rights to the drug from GlaxoSmithKline. TYKERB is indicated in combination therapy for the treatment of metastatic breast cancer that overexpresses the HER2 receptor.

 
Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate
Our Advantages

 

Why choose us?

After more than ten years of development, the company has established close cooperative relations with many domestic chemical research institutions and has a number of production bases. Production in strict accordance with ISO, GMP,FDA standards, products through strict factory testing, to ensure 100% qualified products.

Chemical Raw Powder Buy CAS 388082-77-7 Lapatinib Ditosylate
 
We are looking forward to your inquiry

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory
Number of Employees
13
Year of Establishment
2011-07-26